Articles by G. A. Hitman (27)

The publication of Diabetes UK position statements and care recommendations

R. I. G. Holt, B. S. Young, G. A. Hitman and K. G. M. M. Alberti

Diabetic Medicine 28 ( 5 ): 507 - 507 , 2011

Obesity and Type 2 diabetes; achieving weight loss

G. A. Hitman and S. Finer

Diabetic Medicine 28 ( 6 ): 627 - 627 , 2011

Sequencing PDX1 (insulin promoter factor 1) in 1788 UK individuals found 5% had a low frequency coding variant, but these variants are not associated with Type 2 diabetes

E. L. Edghill, A. Khamis, M. N. Weedon, M. Walker, G. A. Hitman, M. I. McCarthy, K. R. Owen, S. Ellard, A. T Hattersley and T. M. Frayling

Diabetic Medicine 28 ( 6 ): 681 - 684 , 2011

Diabetes and the older person

G. A. Hitman

Diabetic Medicine 28 ( 7 ): 757 - 757 , 2011

Metabolic syndrome and future risk of diabetes

G. A. Hitman

Diabetic Medicine 28 ( 8 ): 883 - 883 , 2011

Type 1 diabetes: treatment and prevention

G. A. Hitman

Diabetic Medicine 28 ( 10 ): 1139 - 1139 , 2011

Persistent lipid abnormalities in diabetes; are we approaching the treatment optimally?

G. A. Hitman

Diabetic Medicine 28 ( 11 ): 1281 - 1281 , 2011

Sir Harold Himsworth and Insulin insensitivity 75 years on

A. J. Krentz and G. A. Hitman

Diabetic Medicine 28 ( 12 ): 1435 - 1435 , 2011

Hypoglycaemia, analogue insulins; prescribing cost or quality of life?

G. A. Hitman

Diabetic Medicine 29 ( 3 ): 289 - 289 , 2012

Statins and glycaemic control-a cause for concern?

G. A. Hitman

Diabetic Medicine 29 ( 5 ): 557 - 557 , 2012

Fasting, Ramadan and Diabetes

G. A. Hitman

Diabetic Medicine 29 ( 6 ): 695 - 695 , 2012

Costs of diabetes; new figures for Type 1 and Type 2 diabetes

G. A. Hitman

Diabetic Medicine 29 ( 7 ): 835 - 835 , 2012

Access to insulin pump therapy and continuous glucose monitoring - is it an even playing field?

G. A. Hitman

Diabetic Medicine 29 ( 8 ): 971 - 971 , 2012

Fatty liver: cause or consequence

G. A. Hitman

Diabetic Medicine 29 ( 9 ): 1097 - 1097 , 2012

Finally, a UK consensus on the use of HbA1c to diagnose diabetes

G. A. Hitman

Diabetic Medicine 29 ( 11 ): 1349 - 1349 , 2012

Type 1 diabetes from bench to bedside; a dedication to George Eisenbarth

G. A. Hitman

Diabetic Medicine 30 ( 2 ): 133 - 133 , 2013

Ethnicity and social deprivation and its influence on diabetes

G. A. Hitman

Diabetic Medicine 30 ( 4 ): 385 - 386 , 2013

Diabetic ketoacidosis; could we do better?

G. A. Hitman

Diabetic Medicine 30 ( 5 ): 511 - 511 , 2013

GLP-1-based diabetes therapies; trial by media

G. A. Hitman

Diabetic Medicine 30 ( 10 ): 1147 - 1147 , 2013

Insulin degludec: a new insulin for today?

G. A. Hitman

Diabetic Medicine 30 ( 11 ): 1267 - 1267 , 2013

The variable faces of monogenic diabetes

G. A. Hitman

Diabetic Medicine 31 ( 1 ): 1 - 1 , 2014

Audit and good diabetes practice

G. A. Hitman

Diabetic Medicine 31 ( 4 ): 381 - 381 , 2014

Diabetes, sleep and metformin

G. A. Hitman

Diabetic Medicine 31 ( 5 ): 509 - 509 , 2014

Statins and diabetes

G. A. Hitman

Diabetic Medicine 31 ( 6 ): 639 - 639 , 2014

Coffee: friend or foe for diabetes risk?

G. A. Hitman

Diabetic Medicine 31 ( 7 ): 763 - 763 , 2014

Physical activity in Type 2 diabetes: have we got it correct?

G. A. Hitman

Diabetic Medicine 31 ( 8 ): 885 - 885 , 2014

Pre-conception and diabetes: are we doing enough?

G. A. Hitman

Diabetic Medicine 31 ( 9 ): 1021 - 1021 , 2014